Comments
Shares of Indoco Remedies Ltd slumped as much 11.7 per cent to Rs 149.4, their biggest intra-day per cent drop since October 8.
The drug maker's Goa Plant I received a warning letter from the US FDA following an inspection in January.
On January 28, the USFDA concluded its audit at the Goa plant I and issued six observations (483s).
The FDA Form 483 notifies a company's management of objectionable conditions.
The stock down is 22 per cent this year as of the last close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.